| Drug Type Small molecule drug | 
| Synonyms Prestozek Combi | 
| Action inhibitors, blockers | 
| Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors), L-type calcium channel blockers(Voltage-gated L-type calcium channel blockers) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date Poland (09 Mar 2016),  | 
| Regulation- | 
| Molecular FormulaC20H25ClN2O5 | 
| InChIKeyHTIQEAQVCYTUBX-UHFFFAOYSA-N | 
| CAS Registry88150-42-9 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Essential Hypertension | Poland  | 09 Mar 2016 | 





